Find therapies in clinical trials near you – page 47

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Study on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis

Study on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Study on Masupirdine for Treating Agitation in Alzheimer's Dementia Patients

Study on Masupirdine for Treating Agitation in Alzheimer's Dementia Patients

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis